Editors and Authors

Editors: Spanagel, Rainer; Mann, Karl F.

Title: Drugs for Relapse Prevention of Alcoholism, 1st Edition

Copyright 2005 Springer

> Front of Book > Editors

Editors

Rainer Spanagel

Universit t Heidelberg
Abteilung f r Psychopharmakologie
J5, Zentralinstitut f r Seelische Gesundheit
68159 Mannheim
Germany

Karl F. Mann

Klinik f r Abh ngiges Verhalten und
Suchtmedizin
J5, Zentralinstitut f r Seelische Gesundheit
68159 Mannheim
Germany

Series Editors

Michael J. Parnham PhD Prof.

Senior Scientific Advisor

PLIVA Research Institute Ltd
Prilaz baruna Filipovica 29
HR-10000 Zagreb
Croatia

Dr. J. Bruinvels Prof.

Sweelincklaan 75
NL-3723 JC Bilthoven
The Netherlands

P.VII

List of contributors

Ludovico Abenavoli

Institute of Internal Medicine, Catholic University, Gemelli Hospital, L.go A. Gemelli 8, 00168 Rome, Italy

Giovanni Addolorato

Institute of Internal Medicine, Catholic University, Gemelli Hospital, L.go A. Gemelli 8, 00168 Rome, Italy; e-mail: [e-mail]

Roberta Agabio

Department of Neuroscience, University of Cagliari, Viale Diaz 182, 09126 Cagliari, Italy; e-mail: [e-mail]

Daniel Bachteler

Department of Psychopharmacology, University of Heidelberg, Central Institute of Mental Health (CIMH), J5, 68159 Mannheim, Germany; e-mail: [e-mail]

Fabio Caputo

G. Fontana, Center for the Study and Treatment of Alcohol Addiction, University of Bologna, Viale Risorgimento 2, 40136 Bologna, Italy

Mauro A.M. Carai

Department of Neuroscience, University of Cagliari, Viale Diaz 182, 09126 Cagliari, Italy; e-mail: [e-mail]

Giancarlo Colombo

C.N.R. Institute of Neuroscience, Section of Cagliari, Viale Diaz 182, 09126 Cagliari, Italy; e-mail: [e-mail]

Michael S. Cowen

Howard Florey Institute, University of Melbourne, VIC 3010, Australia; e-mail: [e-mail]

Giosu deLorenzi

Institute of Internal Medicine, Catholic University, Gemelli Hospital, L.go A. Gemelli 8, 00168 Rome, Italy

Philippe De Witte

UCL - Biologie du Comportement, Place Croix du Sud, 1 bte 10, 1348 Louvain-la-Neuve, Belgium; e-mail: [e-mail]

Griffith Edwards

National Addiction Centre, Institute of Psychiatry, 4 Windsor Walk, London SE 5AF, UK; e-mail: [e-mail]

Anna Ferrulli

Institute of Internal Medicine, Catholic University, Gemelli Hospital, L.go A. Gemelli 8, 00168 Rome, Italy

Douglas R. Funk

Department of Neuroscience, Center for Addition and Mental Health, Toronto, Ontario, Canada M5S 2S1

Giovanni Gasbarrini

Institute of Internal Medicine, Catholic University, Gemelli Hospital, L.go A. Gemelli 8, 00168 Rome, Italy; e-mail: [e-mail]

Gian Luigi Gessa

Department of Neuroscience, University of Cagliari, Cagliari; and C.N.R. Institute of Neuroscience, Viale Diaz 182, 09126 Cagliari, Italy; e-mail: [e-mail]

Markus Heilig

Laboratory of Clinical and Translational Studies, National Institute of Alcohol Abuse and Alcoholism, National Institiute of Health, 10 Center Drive (10/1E5330), Bethesda, MD, 20892-1108, USA; e-mail:

P.VIII

[e-mail]

Petri Hyyti

Department of Mental Health and Alcohol Research, National Public Health Institute, POB 33, FI-00251 Helsinki, Finland; e-mail: [e-mail]

Bankole A. Johnson

South Texas Addiction Research & Technology Center, Department of Psychiatry, The University of Texas Health Science Center at San Antonio, 3939 Medical Drive, Suite 100, San Antonio, TX 78229-3900, USA; e-mail: [e-mail], and Departments of Psychiatric Medicine and Neuroscience, University of Virginia, P.O. Box 800623, Charlottesville, VA 22908-0623, USA; e-mail: bankolejohnson@ virginia.edu

Henry R. Kranzler

Department of Psychiatry, University of Connecticut Health Center, Farmington, CT 06030-2103, USA; e-mail: [e-mail]

Dieter Ladewig

Department of Substance Use Disorders, Psychiatric University Hospital, Wilhelm Klein-Strasse 27, 4025 Basel, Switzerland; e-mail: [e-mail]

Anh Dzung L

Department of Neuroscience, Center for Addiction and Mental Health, Toronto, Ontario, Canada M5S 2S1; and Department of Pharmacology and Psychiatry, University of Toronto, Toronto, Ontario, Canada M5S 1A8; e-mail: [e-mail]

Lorenzo Leggio

Institute of Internal Medicine, Catholic University, Gemelli Hospital, L.go A. Gemelli 8, 00168 Rome, Italy

Carla Lobina

Department of Neuroscience, University of Cagliari, Viale Diaz 182, 09126 Cagliari, Italy

Karl F. Mann

Department of Addictive Behaviour and Addiction Medicine, University of Heidelberg, Central Institute of Mental Health, J 5, 68159 Mannheim, Germany; e-mail: [e-mail]

Charles P. O'Brien

University of Pennsylvania, Department of Psychiatry/Philadelphia Veterans Affairs Medical Center, Treatment Research Center, 3900 Chestnut Street, Philadelphia, PA 19104-6178, USA; e-mail: [e-mail]

David W. Oslin

University of Pennsylvania, Department of Psychiatry/Philadelphia Veterans Affairs Medical Center, Treatment Research Center, 3900 Chestnut Street, Philadelphia, PA 19104-6178, USA; e-mail: [e-mail]

Helen M. Pettinati

University of Pennsylvania, Department of Psychiatry/Philadelphia Veterans Affairs Medical Center, Treatment Research Center, 3900 Chestnut Street, Philadelphia, PA 19104-6178, USA; e-mail: [e-mail]

John David Sinclair

Department of Mental Health and Alcohol Research, National Public Health Institute (KTL), POB 33, Helsinki 00251, Finland; e-mail: [e-mail]

Rainer Spanagel

Department of Psychopharmacology, Central Institute of Mental Health (CIMH), University of Heidelberg, J5, 68159 Mannheim,

P.IX

Germany; e-mail: [e-mail]

Howard Tennen

Department of Community Medicine and Health Care, University of Connecticut Health Center, Farmington, CT 06030-2103, USA; e-mail: [e-mail]

Todd E. Thiele

Department of Psychology, University of North Carolina, Davie Hall, CB 3270, Chapel Hill, NC 27599-3270, USA

Ulrich von Bardeleben

Psychiatrische Klinik Meiringen, 3860 Meiringen, Switzerland; e-mail: [e-mail]

Friedbert Weiss

Department of Neuropharmacology, The Scripps Research Institute (CVN 15), 10550 North Torrey Pines Road, La Jolla, CA 92037, USA; e-mail: [e-mail]

Gerhard A. Wiesbeck

Department of Substance Use Disorders, Psychiatric University Hospital, Wilhelm-Klein-Strasse 27, 4025 Basel, Switzerland; e-mail: [e-mail]

Advisory Board

J.C. Buckingham

(Imperial College School of Medicine, London, UK)

R.J. Flower

(The William Harvey Research Institute, London, UK)

G. Lambrecht

(J.W. Goethe Universit t, Frankfurt, Germany)